Product
Abemaciclib + Aromatase Inhibitor
1 clinical trial
2 indications
Indication
HER2-negative Metastatic Breast CancerClinical trial
Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management. The MINERVA Trial - A Phase IV TrialStatus: Recruiting, Estimated PCD: 2029-04-01